Adela, Inc.
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $60.0Mattributed |
|---|---|
| Latest round | Funding round, $5.0M, 2026-04-10attributed |
| Founded | 2018 |
| Headquarters | Foster City, CA, USA |
| Industry | bio |
| Stage | unknown |
| Website | adelabio.com |
Adela Bio develops blood-based tests that speed cancer diagnosis and improve disease management. It serves cancer patients across the care continuum, from early screening to post-surgery monitoring and immunotherapy response. Its tissue-free detection platform works across multiple cancer types from a single blood draw.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-10 | Funding round | $5.0M | undisclosed |
Detected tech stack
Cloudflare, amCharts, Google Font API, Google Hosted Libraries, Google Tag Manager, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $5.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Total raised $60.0M | attributed | sec-edgar named as publisher. No document URL on file. |
| Company existence | self-reported | adelabio.com, read 2026-05-05 |
| Description | self-reported | adelabio.com, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $5.0M, 2026-04-10 → Funding round, $5.0M, 2026-04-10, sec-edgar, No document URL on file | Latest round | seed, $5.0M, 2026-04-10 → Funding round, $5.0M, 2026-04-10 | sec-edgar, No document URL on file |
Records begin 2026-09-24. All changes